标普和纳斯达克内在价值 联系我们

Repligen Corporation RGEN NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
61/100
1/7 Pass
SharesGrow Intrinsic Value
$186.82
+42.6%
Analyst Price Target
$183.00
+39.7%

Repligen Corporation (RGEN) has 20 已知的内部人和机构持有人记录. 最大持有人为 EDDLEMAN ROY T 持有 370,000 股. 其他重要持有人包括 HERLIHY WALTER C 和 DAWES KAREN A.

过去12个月,内部人进行了 41 笔交易,涉及 RGEN 股票 — 17 笔买入 (价值为 $9.83M) 和 6 笔卖出 (价值为 $1.91M). 内部人买入超过卖出,可能表明对公司前景有信心.

RGEN 內部人持股

最大持股人
EDDLEMAN ROY T
370,000 股
买入(12个月)
17
$9.83M 价值
卖出(12个月)
6
$1.91M 价值
12个月交易活动
买入 41%
卖出 15%
主要內部人持股
# 姓名 职位 持股数量 最近申报日期 相对规模
1 Eddleman Roy T 10 Percent Owner 370,000 2018-08-13
100%
2 Herlihy Walter C President, CEO 262,430 2015-05-14
71%
3 Dawes Karen A Director 91,821 2025-12-18
25%
4 Hunt Anthony Director 89,062 2026-03-03
24%
5 Snodgres Jon Chief Financial Officer 37,381 2023-05-16
10%
6 Cooper Glenn L Md Director 35,709 2019-05-28
10%
7 Gebski Christine See Remarks 27,419 2024-05-15
7%
8 Loeillot Olivier Chief Executive Officer 25,890 2026-03-23
7%
9 Ryan Thomas F Jr Director 12,337 2021-11-04
3%
10 Rusche James R Senior Vice President 9,895 2016-03-01
3%
11 Douglass Brian Robb Chief Product Officer 8,319 2026-03-03
2%
12 Garland Jason K CFO 8,315 2026-03-23
2%
13 Bylund James Chief Operating Officer 8,315 2026-03-23
2%
14 Benjamin Howard VP Business Development 8,289 2017-05-22
2%
15 Kuriyel Ralf Senior VP, R&d 5,669 2026-03-23
2%
16 Hughes Violetta Chief Accounting Officer 3,914 2025-09-04
1%
17 Muir Glenn P Director 3,366 2025-12-17
1%
18 Goldberg Alfred Lewis Director 1,992 2015-05-26
1%
19 Mhatre Rohin Director 1,800 2025-05-19
0%
20 Barthelemy Nicolas Director 1,800 2025-05-21
0%
近期交易 (过去12个月)
日期 姓名 职位 类型 股数 股价 总价值
2026-03-05 Loeillot Olivier Chief Executive Officer 限制性股票授予 (RSU) 25,890 $141.91 $3.67M
2026-03-05 Bylund James Chief Operating Officer 限制性股票授予 (RSU) 8,315 $141.91 $1.18M
2026-03-05 Garland Jason K CFO 限制性股票授予 (RSU) 8,315 $141.91 $1.18M
2026-03-05 Kuriyel Ralf Senior VP, R&d 限制性股票授予 (RSU) 5,669 $141.91 $804.49K
2026-03-04 Bylund James Chief Operating Officer RSU 预扣税 62 $125.84 $7.8K
2026-03-04 Kuriyel Ralf Senior VP, R&d RSU 预扣税 42 $125.84 $5.29K
2026-03-02 Douglass Brian Robb Chief Product Officer RSU 预扣税 221 $124.97 $27.62K
2026-03-02 Loeillot Olivier Chief Executive Officer RSU 预扣税 1,610 $124.97 $201.2K
2026-02-27 Loeillot Olivier Chief Executive Officer RSU 预扣税 344 $128.73 $44.28K
2026-03-02 Bylund James Chief Operating Officer RSU 预扣税 2,433 $124.97 $304.05K
2026-02-27 Bylund James Chief Operating Officer RSU 预扣税 1,478 $128.73 $190.26K
2026-03-02 Garland Jason K CFO RSU 预扣税 715 $124.97 $89.35K
2026-02-27 Garland Jason K CFO RSU 预扣税 327 $128.73 $42.09K
2026-03-02 Kuriyel Ralf Senior VP, R&d RSU 预扣税 923 $124.97 $115.35K
2026-02-27 Kuriyel Ralf Senior VP, R&d RSU 预扣税 444 $128.73 $57.16K
2026-03-02 Hunt Anthony Director RSU 预扣税 9,897 $124.97 $1.24M
2025-12-31 Douglass Brian Robb Chief Product Officer 限制性股票授予 (RSU) 2,143 $163.86 $351.15K
2025-12-31 Douglass Brian Robb Chief Product Officer 未知 7,020 $167.72 $1.18M
2025-12-17 Dawes Karen A Director 知情卖出 275 $161.00 $44.28K
2025-12-16 Muir Glenn P Director 期权行权 3,366 $26.12 $87.92K
2025-12-04 Hunt Anthony Director 其他(卖出) 2,000 - -
2025-11-25 Loeillot Olivier Chief Executive Officer 知情卖出 7,041 $170.00 $1.2M
2025-11-18 Bylund James Chief Operating Officer 知情卖出 2,191 $151.21 $331.3K
2025-11-13 Hunt Anthony Director 期权行权 2,952 $33.87 $99.98K
2025-11-12 Hunt Anthony Director 知情卖出 464 $158.51 $73.55K
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言